144 related articles for article (PubMed ID: 2859776)
1. Clinical pharmacology of acebutolol.
Ryan JR
Am Heart J; 1985 May; 109(5 Pt 2):1131-6. PubMed ID: 2859776
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic properties of acebutolol: relationship of hydrophilicity to central nervous system penetration.
Abernethy DR; Arendt RM; Greenblatt DJ
Am Heart J; 1985 May; 109(5 Pt 2):1120-5. PubMed ID: 2859774
[TBL] [Abstract][Full Text] [Related]
3. Acebutolol: ten years of experience.
De Bono G; Kaye CM; Roland E; Summers AJ
Am Heart J; 1985 May; 109(5 Pt 2):1211-3. PubMed ID: 2859785
[TBL] [Abstract][Full Text] [Related]
4. Comparison of beta-adrenoceptor selectivity of acebutolol and its metabolite diacetolol with metoprolol and propranolol in normal man.
Thomas MS; Tattersfield AE
Eur J Clin Pharmacol; 1986; 29(6):679-83. PubMed ID: 2872056
[TBL] [Abstract][Full Text] [Related]
5. Effects of equipotent blocking doses of acebutolol, acebutolol's primary metabolite, and propranolol on left ventricular hemodynamics in conscious awake dogs.
Magder S; Rubenson D; Griffin G; Kernoff R; Harrison DC
J Cardiovasc Pharmacol; 1983; 5(4):691-6. PubMed ID: 6193369
[TBL] [Abstract][Full Text] [Related]
6. [Acebutolol and diacetolol: their binding to plasma proteins and erythrocytes and secretion with the saliva].
Kukes VG; Gneushev ET; Mamedov TSh; Gneusheva IA
Farmakol Toksikol; 1991; 54(1):53-5. PubMed ID: 1860501
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive effect of diacetolol in essential hypertension.
Thibonnier M; Flabeau C; Thouvenin M; Roux A; Flouvat B; Pasquier P; Menard J
Br J Clin Pharmacol; 1982 Apr; 13(4):533-7. PubMed ID: 6121577
[TBL] [Abstract][Full Text] [Related]
8. A pharmacokinetic study of acebutolol in aged subjects as compared to young subjects.
Roux A; Henry JF; Fouache Y; Chau NP; Hervy MP; Forette F; Bourdarias JP; Flouvat B
Gerontology; 1983; 29(3):202-8. PubMed ID: 6852547
[TBL] [Abstract][Full Text] [Related]
9. A case of fatal acebutolol poisoning: an illustration of the potential of molecular networking.
Le Daré B; Allard S; Bouvet R; Baert A; Allard PM; Morel I; Gicquel T
Int J Legal Med; 2020 Jan; 134(1):251-256. PubMed ID: 30997571
[TBL] [Abstract][Full Text] [Related]
10. The influence of renal function on plasma levels and urinary excretion of acebutolol and its main N-acetyl metabolite.
Kirch W; Köhler H; Berggren G; Braun W
Clin Nephrol; 1982 Aug; 18(2):88-94. PubMed ID: 7140021
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of acebutolol and its main metabolite, diacetolol after oral administration of acebutolol in rabbits with carbon tetrachloride-induced hepatic failure.
Choi JS; Burm JP
Arch Pharm Res; 2002 Aug; 25(4):541-5. PubMed ID: 12214869
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and bioavailability of diacetolol, the main metabolite of acebutolol.
Flouvat B; Roux A; Chau NP; Viallet M; Andre-Fouet X; Woehrle R; Gregoire J
Eur J Clin Pharmacol; 1981 Mar; 19(4):287-92. PubMed ID: 7286031
[TBL] [Abstract][Full Text] [Related]
13. A double-blind comparison of acebutolol (Sectral) and propranolol (Inderal) in the treatment of hypertension in black Nigerian patients.
Abengowe CU
J Int Med Res; 1985; 13(2):116-21. PubMed ID: 2860041
[TBL] [Abstract][Full Text] [Related]
14. The effect of hydralazine on the pharmacokinetics of three different beta adrenoceptor antagonists: metoprolol, nadolol, and acebutolol.
Jack DB; Kendall MJ; Dean S; Laugher SJ; Zaman R; Tenneson ME
Biopharm Drug Dispos; 1982; 3(1):47-54. PubMed ID: 6123352
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the beta 1 and beta 2 adrenoceptor blocking properties of acebutolol and propranolol.
Whitsett TL; Levin DC; Manion CV
Chest; 1982 Dec; 82(6):668-73. PubMed ID: 6128186
[TBL] [Abstract][Full Text] [Related]
16. Enantioselective high performance liquid chromatographic assay of acebutolol and its active metabolite diacetolol in human serum.
Szymura-Oleksiak J; Walczak M; Bojarski J; Aboul-Enein HY
Chirality; 1999; 11(4):267-71. PubMed ID: 10224653
[TBL] [Abstract][Full Text] [Related]
17. Beta-blocking potency and electrophysiologic effects of acebutolol.
Singh BN; Williams R; Harrison DC
Am Heart J; 1985 May; 109(5 Pt 2):1126-31. PubMed ID: 2859775
[TBL] [Abstract][Full Text] [Related]
18. To nurse when receiving acebutolol: is it dangerous for the neonate?
Boutroy MJ; Bianchetti G; Dubruc C; Vert P; Morselli PL
Eur J Clin Pharmacol; 1986; 30(6):737-9. PubMed ID: 3770068
[TBL] [Abstract][Full Text] [Related]
19. In vitro studies on the pharmacological properties of diacetolol, the major metabolite of acebutolol in man.
Borchard U; Hafner D; Hirth C
Arch Int Pharmacodyn Ther; 1985 Jan; 273(1):4-17. PubMed ID: 2860878
[TBL] [Abstract][Full Text] [Related]
20. [Hypertensive heart. Experience in the clinical use of sectral (acebutolol)].
Kardiologiia; 1992; 32(11-12):85-98. PubMed ID: 1363671
[No Abstract] [Full Text] [Related]
[Next] [New Search]
